Reagents and methods for detecting

1. A kit, comprising:

(a) at least one oligonucleotide consisting of at least 90% sequence identity with SEQ ID NO: 68 or with full complements thereof;

(b) at least one oligonucleotide selected from the group consisting of: SEQ ID NOS: 69, 70, a substantially identical variant thereof wherein the variant has at least 90% sequence identity to one of SEQ ID NOS:69, 70, and with full complements of SEQ ID NOS: 69, 70, and the variant; and

(c) instructions for determining a presence of Neisseria gonorrhoeae in a sample by monitoring binding between nucleic acids and/or amplicons thereof from the sample and the oligonucleotide, wherein the presence of Neisseria gonorrhoeae in the sample is unknown or unsubstantiated.

2. The kit of claim 1 , further comprising one or more nucleic acid detection reagents that detectably bind to a Chlamydia trachomatis nucleic acid.

3. The kit of claim 2 , further comprising at least one enzyme.

4. A method of detecting Neisseria gonorrhoeae in a sample, the method comprising:

(a) contacting nucleic acids from the sample with at least a first set of oligonucleotides in a nucleic acid amplification reaction, the first set of oligonucleotides comprising:

a first oligonucleotide consisting of at least 90% sequence identity with SEQ ID NO: 68 or with full complements thereof, and

a second oligonucleotide selected from the group consisting of: SEQ ID NOS: 69, 70, a substantially identical variant thereof wherein the variant has at least 90% sequence identity to one of SEQ ID NOS: 69, 70, and with full complements of SEQ ID NOS: 69, 70, and the variant; and

(b) detecting one or more amplicons thereof from the nucleic acid amplification reaction during or after (a),

thereby detecting the Neisseria gonorrhoeae in the sample.

5. The method of claim 4 , wherein (a) comprises contacting the nucleic acids from the sample with at least a second set of oligonucleotides in the nucleic acid amplification reaction, the second set of oligonucleotides being at least partially complementary to a Chlamydia trachomatis nucleic acid, and wherein (b) comprises detecting one or more additional amplicons from the nucleic acid amplification reaction during or after (a), thereby detecting Chlamydia trachomatis in the sample.

6. The method of claim 4 , wherein at least one of the oligonucleotides comprises a modified nucleic acid.

7. The method of claim 4 , wherein at least one of the oligonucleotides comprises at least one label and/or at least one quencher moiety.

8. The method of claim 7 , wherein (b) comprises detecting a detectable signal produced by the label, or amplifying a detectable signal produced by the label to produce an amplified signal and detecting the amplified signal.

9. The method of claim 7 , wherein (b) comprises monitoring binding between the one or more amplicons and at least one of the oligonucleotides.